President, CEO & Chairman of St. Jude Medical Inc. (STJ, Financial) Daniel J Starks sells 50,000 shares of STJ on 09/09/2009 at an average price of $39.07 a share.
St. Jude Medical Inc. is dedicated to making life better for cardiac neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management atrial fibrillation cardiac surgery cardiology and neuromodulation. St. Jude Medical Inc. has a market cap of $13.72 billion; its shares were traded at around $39.43 with a P/E ratio of 16.7 and P/S ratio of 3.1. St. Jude Medical Inc. had an annual average earning growth of 19.5% over the past 10 years. GuruFocus ranked the business predictability of St. Jude Medical Inc. 4.5-star.
STJ is in the portfolios of Edward Owens of Vanguard Health Care Fund, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of St. Jude Medical Inc. by CEO:
Recent Trades of St. Jude Medical Inc. by CFO:
Recent Trades of St. Jude Medical Inc. by Directors and Officers:
St. Jude Medical Inc. is dedicated to making life better for cardiac neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management atrial fibrillation cardiac surgery cardiology and neuromodulation. St. Jude Medical Inc. has a market cap of $13.72 billion; its shares were traded at around $39.43 with a P/E ratio of 16.7 and P/S ratio of 3.1. St. Jude Medical Inc. had an annual average earning growth of 19.5% over the past 10 years. GuruFocus ranked the business predictability of St. Jude Medical Inc. 4.5-star.
STJ is in the portfolios of Edward Owens of Vanguard Health Care Fund, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of St. Jude Medical Inc. by CEO:
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 shares of STJ stock on 07/30/2009 at the average price of $38.1; the price of the stock has increased by 3.49% since.
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 more shares of STJ stock on 07/28/2009 at the average price of $38.95; the price of the stock has increased by 1.23% since.
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 more shares of STJ stock on 06/04/2009 at the average price of $40.31; the price of the stock has decreased by 2.18% since.
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 more shares of STJ stock on 06/02/2009 at the average price of $40.47; the price of the stock has decreased by 2.57% since.
Recent Trades of St. Jude Medical Inc. by CFO:
- Sell: Executive VP & CFO John C Heinmiller sold 50,000 shares of STJ stock on 05/07/2009 at the average price of $35.04; the price of the stock has increased by 12.53% since.
Recent Trades of St. Jude Medical Inc. by Directors and Officers:
- Buy: Director John W Brown bought 10,000 shares of STJ stock on 05/07/2009 at the average price of $35.26; the price of the stock has increased by 11.83% since.
- Buy: President, ANS Division Christopher G Chavez bought 15,000 shares of STJ stock on 05/01/2009 at the average price of $33.17; the price of the stock has increased by 18.87% since.
- Buy: Director Barbara B Hill bought 1,450 shares of STJ stock on 04/24/2009 at the average price of $34.53; the price of the stock has increased by 14.19% since.
- Sell: President, CRMD Eric S Fain sold 52,500 shares of STJ stock on 07/24/2009 at the average price of $37.79; the price of the stock has increased by 4.34% since.
- Sell: Director Thomas H Iii Garrett sold 10,000 shares of STJ stock on 05/08/2009 at the average price of $36; the price of the stock has increased by 9.53% since.
